|
| 36283503 | Value Based Payment Shift for Independent Urology Practices: Roadmap and Barriers. | Urology | 2023 |
| 32958451 | Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Compared with Conventional Imaging for Initial Staging of Treatment-naïve Intermediate- and High-risk Prostate Cancer: A Retrospective Single-center Study. | Eur Urol Oncol | 2022 |
| 33026934 | Predicting Pathological Tumor Size in Prostate Cancer Based on Multiparametric Prostate Magnetic Resonance Imaging and Preoperative Findings. | J Urol | 2021 |
| 33542230 | Prostate cancer. | Nat Rev Dis Primers | 2021 |
| 34460182 | Modeling financial outcomes and quantifying risk in episode-based payment models. | Am J Manag Care | 2021 |
| 34104782 | Improving Shared Decision Making in Latino Men With Prostate Cancer: A Thematic Analysis. | MDM Policy Pract | 2021 |
| 31537483 | Positive surgical margins at radical prostatectomy in the United States: Institutional variations and predictive factors. | Urol Oncol | 2020 |
| 31898128 | Longitudinal Associations Between Healthcare Resources, Policy, and Firearm-Related Suicide and Homicide from 2012 to 2016. | J Gen Intern Med | 2020 |
| 32072229 | The association between N-methylnaltrexone, a peripherally acting mu-opioid receptor antagonist, and clinical outcomes in patients undergoing robotic-assisted radical cystectomy. | World J Urol | 2020 |
| 31680423 | Using spatial tracking with magnetic resonance imaging/ultrasound-guided biopsy to identify unilateral prostate cancer. | BJU Int | 2020 |
| 32861253 | Analysis of guideline recommended use of renal mass biopsy and association with treatment. | Can J Urol | 2020 |
| 31202786 | Focal Therapy Should Not Be Considered for Men with Gleason Grade Group 3-5 Prostate Cancer. | Eur Urol Focus | 2020 |
| 30446452 | Variation in surgical treatment patterns for patients with prostate cancer in the United States: Do patients in academic hospitals fare better? | Urol Oncol | 2019 |
| 30200775 | Editorial Comment on: Surgical Approach Does Not Impact Margin Status After Partial Nephrectomy for Large Renal Masses by Ayangbesan et al. (From: Ayangbesan A, Golombos DM, Golan R, et al. J Endourol 2019;33:50-60; DOI: 10.1089/end.2018.0144). | J Endourol | 2019 |
| 31306670 | Predicting Short-term Outcomes After Radical Cystectomy Based on Frailty. | Urology | 2019 |
| 31042322 | Do contemporary imaging and biopsy techniques reliably identify unilateral prostate cancer? Implications for hemiablation patient selection. | Cancer | 2019 |
| 31009291 | Financial Margins for Prostate Cancer Surgery: Quantifying the Impact of Modifiable Cost Inputs in an Episode Based Reimbursement Model. | J Urol | 2019 |
| 30930099 | Cytoreductive nephrectomy in patients with metastatic renal cell carcinoma and venous thrombus-Trends and effect on overall survival. | Urol Oncol | 2019 |
| 30267197 | Treatment utilization and overall survival in patients receiving radical nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma: evaluation of updated treatment guidelines. | World J Urol | 2019 |
| 30509763 | Detection of Individual Prostate Cancer Foci via Multiparametric Magnetic Resonance Imaging. | Eur Urol | 2019 |
| 29066013 | Role of surgical approach on lymph node dissection yield and survival in patients with upper tract urothelial carcinoma. | Urol Oncol | 2018 |
| 37312377 | Editorial Commentary. | Urol Pract | 2018 |
| 30228094 | Association between renal mass biopsy and upstaging to perinephric fat involvement in a contemporary cohort of patients with clinical T1a renal cell carcinoma. | Urol Oncol | 2018 |
| 28479237 | Adjuvant Therapy for High Risk Localized Kidney Cancer: Emerging Evidence and Future Clinical Trials. | J Urol | 2018 |
| 29682726 | Where there is smoke, there is not always fire. | Cancer | 2018 |
| 29128421 | Trends in usage of cytoreductive partial nephrectomy and effect on overall survival in patients with metastatic renal cell carcinoma. | Urol Oncol | 2018 |
| 29103965 | Overall survival in patients with metastatic renal cell carcinoma and clinical N1 disease undergoing cytoreductive nephrectomy and lymph node dissection. | Urol Oncol | 2018 |
| 29031667 | Editorial Comment. | J Urol | 2018 |
| 29299664 | Trends in urinary diversion after radical cystectomy for urothelial carcinoma. | World J Urol | 2018 |
| 28725589 | Multi-parametric magnetic resonance imaging as a management decision tool. | Transl Androl Urol | 2017 |
| 28088432 | Detection of Upper Tract Urothelial Malignancies by Computed Tomography Urography in Patients Referred for Hematuria at a Large Tertiary Referral Center. | Urology | 2017 |
| 28088431 | Author Reply. | Urology | 2017 |
| 27346032 | Integrating Patient Preference into Treatment Decisions for Men with Prostate Cancer at the Point of Care. | J Urol | 2016 |
| 27424815 | Urinary Reconstruction after Radical Cystectomy. | J Urol | 2016 |
| 25072182 | Preoperatively misclassified, surgically removed benign renal masses: a systematic review of surgical series and United States population level burden estimate. | J Urol | 2015 |
| 25882565 | Surgical advances in bladder cancer: at what cost? | Urol Clin North Am | 2015 |
| 25806885 | Improving couples' quality of life through a Web-based prostate cancer education intervention. | Oncol Nurs Forum | 2015 |
| 25240535 | Nutritional predictors of complications following radical cystectomy. | World J Urol | 2015 |
| 24274722 | Neoadjuvant chemotherapy for bladder cancer does not increase risk of perioperative morbidity. | BJU Int | 2014 |
| 24958478 | Editorial comment. | Urology | 2014 |
| 23540777 | Perioperative chemotherapy: when to use it, what to use, and why. | Urol Clin North Am | 2013 |
| 23102129 | Robotic intracorporeal urinary diversion: ileal conduit. | J Endourol | 2012 |